Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova

Introduction: In Italy, on December 2020, workers in the education sector were identified as a priority population to be vaccinated against COVID-19. The first authorised vaccines were the Pfizer-BioNTech mRNA (BNT162b2) and the Oxford-AstraZeneca adenovirus vectored (ChAdOx1 nCoV-19) vaccines. Aim:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Paola, Rizzuto, Rosario, Iannelli, Luca, Baccaglini, Flavio, Rizzolo, Valerio, Baraldo, Andrea, Melloni, Barbara, Maffione, Francesca, Pezzoli, Camilla, Chiozza, Maria Laura, Rupolo, Giampietro, Biasioli, Marco, Liviero, Filippo, Scapellato, Maria Luisa, Trevisan, Andrea, Merigliano, Stefano, Scuttari, Alberto, Moretto, Angelo, Scarpa, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221025/
https://www.ncbi.nlm.nih.gov/pubmed/37243055
http://dx.doi.org/10.3390/vaccines11050951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221025/
https://www.ncbi.nlm.nih.gov/pubmed/37243055
http://dx.doi.org/10.3390/vaccines11050951

Ejemplares similares